ASCO 2023

Oncology
ASCO 2023 – Dr Lalan Wilfong

ASCO 2023 – Dr Lalan Wilfong

In the last video from ASCO 2023, we step away from the R&D side to talk about drug costs and payment models.

Oncology
ASCO 2023 Jaydev Thakkar

ASCO 2023 – Jaydev Thakkar

In our penultimate video from ASCO 2023, editor-in-chief Jonah Comstock touches base with Biofourmis chief operating officer Jaydev Thakkar.

Oncology
ASCO 2023 Mark Reisenauer

ASCO 2023 – Mark Reisenauer

As we approach the last of our exclusive coverage of ASCO 2023, editor-in-chief Jonah Comstock speaks with Mark Reisenauer, president of US commercial at Astellas.

Oncology
ASCO 2023 Warner Biddle

ASCO 2023 – Warner Biddle

While ASCO 2023 didn’t have too much focus on cell therapies, because of their lack of impact so far on the solid tumour space, Kite, a Gilead company, did share new data on Yescarta for la

Oncology
ASCO 2023 Jennifer Elliott

ASCO 2023 – Jennifer Elliott

Some of the most impactful news out of ASCO 2023 dealt with new treatments for patients with few options in the status quo of cancer care.